The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
Research shows the average Briton spends more than £100 each year on non-prescription medicines such as cough syrup and ...
TipRanks on MSN
Vistagen’s Phase 3 Trial of Fasedienol Nasal Spray: A Potential Game-Changer for Anxiety Treatment
Vistagen Therapeutics Inc. (($VTGN)) announced an update on their ongoing clinical study. Vistagen Therapeutics Inc. is conducting a Phase 3 ...
TipRanks on MSN
Smith & Nephew’s REFLEX ULTRA 45 Study: A Potential Game-Changer in Nasal Obstruction Treatment
Smith & Nephew Snats (($SNN)) announced an update on their ongoing clinical study. Smith & Nephew is currently conducting a post-market clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback